Compare AGIO & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGIO | SHO |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2013 | 1995 |
| Metric | AGIO | SHO |
|---|---|---|
| Price | $26.87 | $9.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 8 |
| Target Price | ★ $32.13 | $9.31 |
| AVG Volume (30 Days) | ★ 2.7M | 1.9M |
| Earning Date | 10-30-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 3.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $44,791,000.00 | ★ $937,930,000.00 |
| Revenue This Year | $28.75 | $5.75 |
| Revenue Next Year | $139.45 | $5.65 |
| P/E Ratio | ★ N/A | $962.16 |
| Revenue Growth | ★ 36.26 | 3.04 |
| 52 Week Low | $22.24 | $7.45 |
| 52 Week High | $46.00 | $12.41 |
| Indicator | AGIO | SHO |
|---|---|---|
| Relative Strength Index (RSI) | 35.66 | 51.63 |
| Support Level | $26.80 | $8.84 |
| Resistance Level | $28.61 | $9.48 |
| Average True Range (ATR) | 1.15 | 0.19 |
| MACD | 0.28 | 0.01 |
| Stochastic Oscillator | 16.59 | 58.59 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.